龙胆泻肝汤治疗原发性肝癌TACE术后栓塞综合征的疗效观察

陈学武; 姜靖雯; 林福煌

龙胆泻肝汤治疗原发性肝癌TACE术后栓塞综合征的疗效观察

1.
海南省中医院肿瘤科，海南海口 570203
2.
海南省人民医院介入治疗科，海南海口 570301

计量
- 文章访问数: 899
- HTML全文浏览量: 8
- PDF下载量: 694
出版历程
- 刊出日期: 2016-05-09

Longdan Xiegan Decoction in the Treatment of Embolism Syndrome after Interventional Therapy on Primary Hepatocellular Carcinoma

1.
Oncology Department of Hainan Provincial Hospital of Traditional Chinese Medicine, Haikou, 570203, China
2.
Interventional Treating Department of Hainan General Hospital, Haikou, 570301, China

摘要

摘要: 目的观察龙胆泻肝汤治疗原发性肝癌肝动脉超选择化疗栓塞（TACE）术后栓塞综合征的疗效。方法将60例原发性肝癌经TACE治疗后的患者随机分为治疗组30例和对照组30例。对照组接受西药对症支持治疗，治疗组在对症治疗的基础上加用龙胆泻肝汤加减口服治疗。4周后观察疗效。结果治疗后2组患者的有效率无显著性差异（P>0.05），治疗组的栓塞后综合征严重程度明显低于对照组（P<0.05），中医证候积分明显低于对照组（P<0.05），中医证候改善率明显高于对照组（P<0.05），生活质量明显优于对照组（P<0.05），治疗组的肝功能水平较对照组下降明显（P<0.05），甲胎蛋白（AFP）水平明显低于对照组（P<0.05）。结论加服龙胆泻肝汤治疗TACE术后栓塞综合征疗效较好，可临床推广。
- 龙胆泻肝汤 /
- 原发性肝癌 /
- TACE术 /
- 栓塞综合征
Abstract: OBJECTIVE To observe the effect of Longdan Xiegan decoction in treating embolism syndrome after interventional therapy on primary hepatocellular carcinoma. METHODS Sixty patients with primary cancer after interventional therapy were randomly divided into two groups: the treatment group(30 cases) and the control group(30 cases). The control group was treated by western medicine and the treatment group， besides taking western medicine， took oral-taken Longdan Xiegan decoction as well for six weeks. RESULTS The effective rates of both groups showed no significant difference(P>0.05). After one week of treatment， the severity degree of the treatment group was much lower than that of the control group(P<0.05). After two weeks' treatment， the TCM score of the treatment group was much lower than that of the control group(P<0.05). The treatment group showed significant improvement in the TCM syndromes(P<0.05). The life quality of the treatment group was much better than that of the control group after two weeks' treatment(P<0.05). After two weeks' treatment， the treatment group showed significant decrease in the liver function(P<0.05). CONCLUSION The combination of Longdan Xiegan decoction and western medicine are more effective in treating embolism syndrome after interventional therapy on primary hepatocellular carcinoma.
- Longdan Xiegan decoction /
- primary hepatocellular carcinoma /
- TACE /
- embolism syndrome

HTML全文

参考文献(24)

[1]	原发性肝癌诊断标准[J].中华肝脏病杂志，2000，8(3):135.
[2]	Standard of the diagnosis of primary hepatocellular carcinoma[J]. Chin J Hepatol， 2000，8(3):135.
[3]	中药新药临床研究指导原则[M]．北京：中国医药科技出版社，2002:120-124．
[4]	Guiding Principals of Clinical Application of TCM New Drugs[M]. Beijing: China medical science press， 2002:120-124.
[5]	孙燕，石元凯．实用肿瘤内科学[M]．北京：人民卫生出版社，1999:32-33．
[6]	Sun Y， Shi YK. Medical Oncology[M]. Beijing: People's medical publishing house， 1999: 32-33.
[7]	抗癌药急性及亚急性毒性反应分度标准(WHO标准)[J]．癌症，1992，11（3）：254．
[8]	Grading system of acute and subacute toxicity reaction of anti-cancer drugs(WHO standard)[J]. Chin J Cancer 1992，11(3):254.
[9]	Zacharias AJ， Jayakrishnan TT， Rajeev R， et al. Comparative effectiveness of hepatic artery based therapies for unresectable colorectal liver metastases: a Meta-Analysis[J]. PLoS One， 2015， 10(10): e0139940.
[10]	Brown DB， Cardella JF， Sacks D， et al. Quality improvement guidelines for transhepatic arterial chemoembolization， embolization， and chemotherapeutic infusion for hepatic malignancy[J]. J Vasc Interv Radiol， 2006， 17(3): 225-232.
[11]	刘文导，梅世伟，孟凡喆，等．健脾补肾方联合针灸治疗对原发性肝癌肝动脉化疗栓塞术后综合征细胞免疫功能的调节[J]．吉林中医药，2014，34（12）：1222-1224．
[12]	Liu WD， Mei SW， Meng FZ， et al. Effect of Jianpi Bushen Prescription combined with acupuncture treatment on cellular immune function regulation of hepatocellular carcinoma patients with postoperative syndrome after TACE[J]. Jilin J Tradit Chin Med， 2014， 34(12):1222-1224.
[13]	鲁维德，刘晓东，王兴东，等．裴氏胆胰颗粒治疗肝癌介入栓塞术后综合征28例[J]．中医研究，2013，26（5）：22-24．
[14]	Lu WD， Liu XD， Wang XD， et al. Pei's pancreaticobiliary particles in treating 28 cases of embolism syndrome after interventional therapy on primary hepatocellular carcinoma[J]. Tradit Chin Med Res， 2013， 26(5):22-24.
[15]	莫春梅，荣震，吕建林，等．敷和备化方联合雷火灸治疗原发性肝癌介入术后综合征40例临床观察[J]．时珍国医国药，2014，25（2）：378-379．
[16]	Mo CM， Rong Z， Lü JL， et al. Fuhe Beihua Fang together with thunder-fire moxibustion in treating embolism syndrome after interventional therapy on primary hepatocellular carcinoma: a study of 40 cases[J]. Lishizhen Med Mater Med Res， 2014，25(2):378-379.
[17]	钟毅，周红，陈春泳．甘露消毒丹加味治疗原发性肝癌介入栓塞后综合征50例[J]．河南中医，2002，22（4）：20-21．
[18]	Zhong Y， Zhou H， Chen CY. Ganlu Xiaodudan with modification for treating 50 cases of post-embolism syndrome of primitive carcinoma of liver[J]. Henan Tradit Chin Med， 2002， 22(4):20-21.
[19]	李永伟，杨宏志，王拥泽，等．大柴胡汤加减治疗肝癌TACE术后栓塞综合征[J]．中国医药导报，2012，9（28）：107-108， 110．
[20]	Li YW， Yang HZ， Wang YZ， et al. Dachaihu decoction in the treatment of embolism syndrome after interventional therapy on primary hepatocellular carcinoma[J]. Chin Guid J Tradit Chin Med Pharmacol， 2012， 9(28):107-108，110.
[21]	陶莉莉，张玉珍，桑霞，等．加减龙胆泻肝汤对肝经郁火型多囊卵巢综合征患者高雄激素血症的影响[J]．中国中西医结合杂志，2006，26（9）：838-841．
[22]	Tao LL， Zhang YZ， Sang X， et al. Effects of modified longdan xiegan decoction on hyperandrogenism in patients with polycystic ovary syndrome of stagnant fire in Gan Channel type[J]. Chin J Integr Med， 2006， 26(9): 838-841.
[23]	罗继红，覃倩倩．龙胆泻肝汤治疗湿热型慢性湿疹40例临床观察[J]．长春中医药大学学报，2013，29（2）：304-305．
[24]	Luo JH， Tan QQ. Treatment of chronic eczema with damp-heat syndrome by Longdan Xiegan decoction in 40 cases[J]. J Changchun Coll Tradit Chin Med， 2013， 29(2):304-305.

施引文献

资源附件(0)

计量

文章访问数: 899
HTML全文浏览量: 8
PDF下载量: 694
被引次数: 0

龙胆泻肝汤治疗原发性肝癌TACE术后栓塞综合征的疗效观察

计量

出版历程

Longdan Xiegan Decoction in the Treatment of Embolism Syndrome after Interventional Therapy on Primary Hepatocellular Carcinoma

计量

出版历程

目录